|
|
Article: Controversy About Lack of Placebo Group Decline in Alzheimers Clinical Trials
- Article from:
- U.S. Newswire
- Article date:
- July 28, 2008
CopyrightCopyright 2008 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: NATIONAL EDITORS
Contact: Alzheimers Association media line: +1-312-335-4078,
media@alz.org, ICAD 2008 press room, July 27-31: +1-312-949-3253
- Two Large-Scale Analyses Have Conflicting Results -
CHICAGO, July 28 /PRNewswire-USNewswire/ -- Lack of measureable
decline in memory and thinking processes among placebo groups in
Alzheimers disease clinical trials might reduce the ability to show
the effectiveness of new Alzheimer therapies, according to new
research reported today at the 2008 Alzheimers Association
International Conference on Alzheimer's Disease (ICAD 2008) in
Chicago.
Alzheimer clinical trials seek to show that those who received
the treatment improved over the course of ...